You're reading the free version. Trader adds the live tape and alerts.
Start tracking
IDXG Exercise Disclosure
Mccarthy Christopher · SEC Form 4 · Filed Aug 20, 2026
Exercise
Calculated transaction value
$0
Mccarthy Christopher CFO & COO
IDXG
Transaction date
Aug 20, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed same day
IDXG daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 277,009 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001493152-26-039495
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Interpace Biosciences, Inc. IDXG | Award | Aug 20, 2026 | $0 |
| Interpace Biosciences, Inc. IDXG | Exercise | Aug 20, 2026 | $0 |
| Interpace Biosciences, Inc. IDXG | Award | Aug 20, 2026 | $0 |
| Interpace Biosciences, Inc. IDXG Current | Exercise | Aug 20, 2026 | $0 |